Showing results (351-360 of 475) with videos related to
Sort By:
Pageof 48
European Urology Focus|February 1, 2022
Evaluation and Treatment in Urology for Nocturia Caused by Nonurological Mechanisms: Guidance from the PLANET StudyMatthew Smith, Shoba Dawson, Robert C Andrews, et al.Reproductive Health|May 27, 2021
Reproductive health decision making among nomadic pastoralists in North Eastern Kenya: a qualitative social network analysisLeah Kenny, Rahma Hassan, Loraine J Bacchus, et al.Sensors (Basel, Switzerland)|November 27, 2024
Knee4Life: Empowering Knee Recovery After Total Knee Replacement Through Digital Health ProtocolMaedeh Mansoubi, Phaedra Leveridge, Matthew Smith, et al.Lancet (London, England)|March 1, 2011
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind studyKarim Fizazi, Michael Carducci, Matthew Smith, et al.European Urology|December 3, 2014
Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate CancerKarim Fizazi, Christophe Massard, Matthew Smith, et al.Malaria Journal|February 19, 2010
Species composition, larval habitats, seasonal occurrence and distribution of potential malaria vectors and associated species of Anopheles (Diptera: Culicidae) from the Republic of KoreaLeopoldo M Rueda, Tracy L Brown, Heung Chul Kim, et al.JAMIA Open|July 23, 2025
Using the Observational Medical Outcomes Partnership Common Data Model for a multi-registry intensive care unit benchmarking federated analysis: lessons learnedAasiyah Rashan, Daniel P Püttmann, Nicolette F de Keizer, et al.The Lancet. Planetary Health|July 22, 2019
Combining the effects of increased atmospheric carbon dioxide on protein, iron, and zinc availability and projected climate change on global diets: a modelling studyRobert H Beach, Timothy B Sulser, Allison Crimmins, et al.Anti-Cancer Agents in Medicinal Chemistry|April 10, 2014
Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer modelsClaudio Festuccia, Giovanni Luca Gravina, Andrea Mancini, et al.European Urology Focus|January 15, 2022
Assessment and Treatment of Nocturia in Neurological Disease in a Primary Care Setting: Systematic Review and Nominal Group Technique ConsensusNadine A M van Merode, Shoba Dawson, Elizabeth Coulthard, et al.Pageof 48